Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qizhiweitong granules in chronic non-atrophic gastritis: metabolomics biomarkers
ChiCTR2100047188Phase 4Recruiting
- Sponsor
- The First Hospital of Hebei Medical University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Qizhi Weitong granules in chronic non-atrophic gastritis (2 arms), sponsored by The First Hospital of Hebei Medical University. Primary endpoints: Endogenous substances in plasma, Endogenous substances in saliva and 1 more. Started Jun 2021; status: recruiting.
02
Drugs
Qizhi Weitong granules
03
Conditions
chronic non-atrophic gastritis
Beyond the preview
Go deeper on ChiCTR2100047188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047188.